CHALNA2
Recruiting
710 enrolled
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
Recruiting
100 enrolled
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Active not recruiting
132 enrolled
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Suspended
2,400 enrolled
TraveraRTGx
Completed
72 enrolled
Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes
Active not recruiting
76 enrolled
Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma
Active not recruiting
1,523 enrolled
ISTAR-01
Recruiting
138 enrolled
ISTAR-02
Recruiting
146 enrolled
ELUCIDATE
Recruiting
400 enrolled
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Recruiting
5,000 enrolled
VOCAL
Completed
56 enrolled
Optimizing Y90 Therapy for Radiation Lobectomy
Recruiting
104 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
Not yet recruiting
400 enrolled
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
Completed
1 enrolled
CCGLC-019
Not yet recruiting
162 enrolled
Treat Primary and Metastatic Liver Tumors
Withdrawn
cfDNA Methylation for Liver Cancer Recurrence Detection
Recruiting
500 enrolled
Evaluation of Resection Techniques for Pancreatic Tumors
Recruiting
431 enrolled
QUS in HCC
Recruiting
328 enrolled
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Recruiting
300 enrolled
A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma
Recruiting
250 enrolled
Individualized Surgical Guidance in HCC-BDTT
Completed
151 enrolled
ELEPHAS-04
Recruiting
324 enrolled
SEEK
Completed
38 enrolled
HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion
Not yet recruiting
150 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
Active not recruiting
1,000 enrolled
Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
Recruiting
15 enrolled
CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC
Completed
324 enrolled
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
Recruiting
200 enrolled
I-GROWtoh
Recruiting
2,000 enrolled
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Enrolling by invitation
1,300 enrolled
DELIVER
Recruiting
270 enrolled
Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy
Recruiting
90 enrolled
Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment
Active not recruiting
60 enrolled
Bio-Delta
Recruiting
20 enrolled
Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation
Completed
484 enrolled
BLOOD-TACE-M
Not yet recruiting
60 enrolled
SWITCH
Not yet recruiting
100 enrolled
Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients
Completed
84 enrolled
RESPECT
Active not recruiting
250 enrolled
LiverINSPECT
Active not recruiting
20 enrolled
NISTIPS
Recruiting
350 enrolled
BLOOD-TACE-P
Recruiting
15 enrolled
GENDER-HCC-MET
Completed
19,019 enrolled
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
Recruiting
730 enrolled
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)
Completed
244 enrolled
3DMPUS
Recruiting
80 enrolled